Nexalin Technology (NXL) Common Equity (2021 - 2026)
Nexalin Technology's Common Equity came in at $1.52 million for Q2 2026, down 74.5% from $5.96 million a year earlier and down 47.4% from the prior quarter.
Powered by 
Analysis
Nexalin Technology (NXL) Common Equity (2021 - 2026) Analysis & Trends
At the end of FY2025, Nexalin Technology's Common Equity was $3.75 million, up 2.0% from FY2024.
- Going back by year, Common Equity was $3.68 million in FY2024 (+14.6%), $3.21 million in FY2023 (-41.5%), $5.48 million in FY2022 and -$1.68 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Common Equity since Q2 2024.
- Year-over-year, Common Equity increased in five of the last eight quarters, with growth averaging 44.6%.
- The fastest year-over-year change in Common Equity over five years came in Q2 2025 (growth of 341.4%), and the weakest in Q2 2026 (a decline of 74.5%).
- Business Quant data shows NXL's Common Equity at $2.89 million (Q1 2026), $3.75 million (Q4 2025) and $4.77 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 52.69 Bn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 51.76 Bn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 52.59 Bn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 18.30 Bn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 23.99 Bn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 25.17 Bn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 10.72 Bn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 24.42 Bn |
| 10 | Nexalin Technology | 3.09 Mn | -8.70 Mn | 8,897.00 | 1.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.52 Mn |
| Mar 31, 2026 | 2.89 Mn |
| Dec 31, 2025 | 3.75 Mn |
| Sep 30, 2025 | 4.77 Mn |
| Jun 30, 2025 | 5.96 Mn |
| Mar 31, 2025 | 2.33 Mn |
| Dec 31, 2024 | 3.68 Mn |
| Sep 30, 2024 | 4.96 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | 2.33 Mn |
| Dec 31, 2023 | 3.21 Mn |
| Sep 30, 2023 | 3.24 Mn |
| Jun 30, 2023 | 3.99 Mn |
| Mar 31, 2023 | 4.74 Mn |
| Dec 31, 2022 | 5.48 Mn |
| Sep 30, 2022 | 6.35 Mn |
| Jun 30, 2022 | -2.24 Mn |
| Mar 31, 2022 | -1.97 Mn |
| Dec 31, 2021 | -1.68 Mn |
| Sep 30, 2021 | -1.97 Mn |
API Access
Nexalin Technology Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=NXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "NXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=NXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();